Ribonucleoside Diphosphate Reductase, antagonists & inhibitors
- Name
- Ribonucleoside Diphosphate Reductase, antagonists & inhibitors
- Accession Number
- DBCAT001805
- Description
Not Available
- Drugs
Drug Drug Description Tezacitabine Investigated for use/treatment in colorectal cancer, lung cancer, leukemia (unspecified), and gastric cancer. - Drugs & Drug Targets
Drug Target Type Tezacitabine Ribonucleoside-diphosphate reductase large subunit target Tezacitabine Thymidine phosphorylase enzyme